课题基金 / 基金详情

PHASE I TRIAL--ESCALATING DOSES OF CONTINUOUS INFUSION OF TOPOTECAN & ETOPOSIDE

PHASE I TRIAL--ESCALATING DOSES OF CONTINUOUS INFUSION OF TOPOTECAN & ETOPOSIDE
I 期试验——增加拓扑替康持续输注剂量
批准号：
3766294
负责人：
JOHN ECKARDT
金额：
$0.0万
依托单位：
UNIVERSITY OF TEXAS HLTH SCIENCE CENTER
依托单位国家：
美国
项目类别：
财政年份：
--
资助国家：
美国
项目状态：
未结题
起止时间：
至
来源：
https://reporter.nih.gov/project-details/3766294
关键词：
DNA topoisomerases antineoplastics camptothecin clinical trials combination cancer therapy combination chemotherapy dosage drug screening /evaluation enzyme inhibitors etoposide human subject human therapy evaluation neoplasm /cancer chemotherapy

项目摘要

项目成果

JOHN ECKARDT的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The purpose of this protocol is to attempt to discover if the combination of topotecan, a Topoisomerase I inhibitor, and etoposide, a Topoisomerase II inhibitor, will have a synergistic effect on cytotoxicity.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PHASE I OF BCNU AND TEMOZOLOMIDE
PHASE I OF LY309887 IN PATIENTS WITH METASTATIC CANCER
PHASE I STUDY OF TOREMIFENE AND DOXORUBICIN IN PATIENTS WITH ADVANCED CANCER
PHASE I STUDY OF TOREMIFENE AND DOXORUBICIN IN PATIENTS WITH ADVANCED CANCER
海外基金